3D bio-printing is believed to bring about a huge revolution to the modern medicine. Imagine in the future, patients in desperate need of organ transplantation no longer have to go through an endless waiting for the matching organs, nor do …
Recently, Mr. Lu Qiqi, General Manager of RunYoung Capital Management Co., Ltd., led a team to Israel for investigation and exchange. During the visit, a number of China-Israel cooperation projects have been confirmed, and the long-awaited surgical robot platform project …
RunYoung was named to the 2020 list of the most active VCs in Israel as the only Chinese VC fund listed on the list. On March 22nd, the latest, “Report on the Most Active Venture Capital Funds in Israel 2020”, was released. RunYoung Investment was honored to be on the list. The report ranks Israeli and foreign venture capital funds based on the number of first-time investment deals (the first time a venture capital fund added a company to its portfolio) in Israeli high-tech companies in the past year. With five successful investments in Israeli startups in a single year, RunYoung Investment tied for ninth place on the list and was the only Chinese venture capital fund listed.
On March 31, 2021, Professor Hong Zhao, Deputy Director of Hepatobiliary Surgery at Cancer Hospital of Chinese Academy of Medical Sciences, and some other outstanding young and middle-aged experts, had in-depth communication with Aaron Ciechanover, the 2004 Nobel Laureate in Chemistry, and his team. The main topic was related to basic medical research and its transformation into clinical practice. Prof. Jianqiang Cai, Vice Director of National Cancer Center/Vice President of Cancer Hospital of Chinese Academy of Medical Sciences, attended the conference and gave the welcoming address.
According to the latest Israel National News, Yoav Galant, Israel’s Minister of Education, announced on February 25th, that this year’s Israel Prize, Israel’s highest national award for life sciences research, will be awarded to Professor Eli Keshet. He is being recognized for his “pioneering contribution” to understanding the mechanism of new blood vessel growth in hypoxic conditions. The award judging panel said that Professor Eli Keshet’s research process “has had a profound impact on the development of many diseases including retinal disease and cancer.”
SHANGHAI & TEL AVIV, Nov. 2, 2020 – The RunYoung Technology Transfer Center (“RunYoung” or “the Fund”) launched with a $50M fund dedicated to investing in Israeli early-stage life sciences companies that have expansion aspirations in China. Early stage life …
On the morning of July 10, 2020, the Signing Ceremony of the West Tai Lake Medical Innovation Projects of Sino-Israeli Cooperation was held at West Tai Lake Medical Technology International Innovation Center in Changzhou. City leaders including Yibo Liang, Zhiliang …
During the month of June 2019, RunYoung signed agreements with four of Israel’s top research institutions: Hebrew University, The Weizmann Institute, Clalit Medical Group and the Technion Technology Transfer Center.
On May 19, 2019, the second China-Israel Medical Technology Industry Summit Forum was held in Changzhou. Honored guests included: Wei He, Director of National Medical Products Administration (NMPA), Member of Central Committee and Vice-Chairman of the Central Standing Committee of …